LA JOLLA – Sylke Inc., a biotech company that has patented a non-immunogenic surgical bandage designed to reduce post-operation infections and complications, reported $5.5 million in new funding in a filing this month with the SEC. Sylke’s fundraise came from 66 investors, the majority of whom are physicians and surgeons from medical systems and academic […]
↧